On February 24th Chairman of the Board of Latvian Institute of Organic Synthesis Ivars Kalviņš bought Rigvir holding shares and became one of the few shareholders. Dr.habil.chem, Professor Ivars Kalviņš has gained international recognition as the author of several hundred publications, more than 550 patents, author of medicine Mildronate, Leokadins and one of the inventors of medicine Belinostat (Beleodaq) registered in 2014 according to the USA FDA standards.
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE
+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)
© 2020 International Virotherapy Center Limited. All Rights Reserved